These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 114247)

  • 1. [Correlation between differentiation and malignancy in human malignant melanocytes "in vivo" and "in vitro" (author's transl)].
    Foa C
    Bull Cancer; 1979; 66(3):235-58. PubMed ID: 114247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
    Aubert C; Rougé F; Galindo JR
    J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastruct and biochemical chantes in cultured human malignant melanoma cells after heterotransplantation into nude mice.
    Aubert C; Chirieceanu E; Foa C; Rorsman H; Rosengren E; Rougé F
    Cancer Res; 1976 Sep; 36(9 pt.1):3106-12. PubMed ID: 975076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation and tumorigenicity of human malignant melanocytes. Comparative study of two "non pigmented" and pigmented lines from the same fibroblastoid cells].
    Aubert C; Rougé F; Galindo JR
    C R Seances Acad Sci D; 1979 Mar; 288(10):919-22. PubMed ID: 111834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
    Eisen T; Easty DJ; Bennett DC; Goding CR
    Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix modulates the function of human melanocytes but not melanoma cells.
    Ranson M; Posen S; Mason RS
    J Cell Physiol; 1988 Aug; 136(2):281-8. PubMed ID: 3137234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural comparison between cultured and tumor cells of human malignant melanoma.
    Foa C; Aubert C
    Cancer Res; 1977 Nov; 37(11):3957-63. PubMed ID: 908035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anatomo-pathologic and ultrastructural study in a case of melanoma in the golden Syrian hamster chemically induced by 9,10 dimethyl-1,2-benzanthracene (DMBA) and transplantable].
    De Micco-Pagis C; Verrier-Ferret C; Bonneau HP; Bonneau H
    Bull Cancer; 1976; 63(1):73-86. PubMed ID: 825163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
    Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
    Larue L; Dougherty N; Bradl M; Mintz B
    Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
    Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
    Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines.
    Boukamp P; Rupniak HT; Fusenig NE
    Cancer Res; 1985 Nov; 45(11 Pt 2):5582-92. PubMed ID: 4053033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes.
    Iyengar B
    Melanoma Res; 1994 Oct; 4(5):293-5. PubMed ID: 7858412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanogenesis in cultured human neuroblastomas.
    Aubert C; Janiaud P; Rouge F; Hansson C; Rorsman H; Rosengren E
    Ann Clin Res; 1980 Dec; 12(6):288-94. PubMed ID: 6786205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
    Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
    Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.